Question 1

What are the differences between Capecitabine tablets and XELODA?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Bioequivalence Study of Capecitabine Tablets clinical trial (NCT01846650). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my eligibility be determined for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Bioequivalence Study of Capecitabine Tablets clinical trial (NCT01846650). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Bioequivalence Study of Capecitabine Tablets clinical trial (NCT01846650). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Bioequivalence Study of Capecitabine Tablets clinical trial (NCT01846650). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Bioequivalence Study of Capecitabine Tablets clinical trial (NCT01846650). Contact the study team or your healthcare provider for specific answers.

Question 6

Can you explain the process for signing up and what it involves?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Bioequivalence Study of Capecitabine Tablets clinical trial (NCT01846650). Contact the study team or your healthcare provider for specific answers.

What this study is about